What is Axitinib?

Axitinib (AG013736; trade name Inlyta) is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models and has shown partial responses in clinical trials with renal cell carcinoma (RCC) and several other tumour types. It was approved by the U.S. Food and Drug Administration after showing a modest increase in progression-free survival, though there have been reports of fatal adverse effects.

Questions and answers on "Axitinib"

My husband has been in Axitinib for about 1 year and more for Kidney cancer. He had some blood clots
in his lung and we were told it was caused by...

doctor1 MD

This is called the targetted therapy. It is used in advanced stage of cancer. the clotting problem is a rare cause with this drug but it is the...

Read Full Thread   Ask a Doctor Now

You should have my history from previous questions I have asked however over 2 years ago I had my left kidney removed and a prot
hesis in my right...

doctor1 MD

Brief Answer:
Hello. You should continue with sutent

Detailed Answer:
Hello dear. Since the scan shows no evidence of disease, you must continue...

Read Full Thread   Ask a Doctor Now

Recent questions on Axitinib

Ask Question
Doctor Image

Hi, I am Dr. Andrew Rynne (Family Physician). I will be guiding you through the process. Please write your question below.

Related Disease & Conditions